24-hour IOP telemetry in the nonhuman primate: Implant system performance and initial characterization of IOP at multiple timescales

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 10, 2011, Pages 7365-7375

  Crawford Downs, J ^a   Burgoyne, Claude F ^b   Seigfreid, William P ^a,c   Reynaud, Juan F ^a,b   Strouthidis, Nicholas G ^d   Sallee, Verney ^e  

^a Ocular Biomechanics Laboratory   (United States)

^b DEVERS EYE INSTITUTE   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d MOORFIELDS EYE HOSPITAL   (United Kingdom)

^e RTOP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANTERIOR EYE CHAMBER; ARTICLE; BODY TEMPERATURE; CALIBRATION; DIGITAL FILTERING; ELECTROCARDIOGRAPHY; FEMALE; IMPLANT; INTRAOCULAR PRESSURE; NOISE REDUCTION; NONHUMAN; PRESSURE TRANSDUCER; PRIORITY JOURNAL; RHESUS MONKEY; TELEMETRY; ANIMAL; CIRCADIAN RHYTHM; INSTRUMENTATION; MACACA MULATTA; METHODOLOGY; PHYSIOLOGY; PROSTHESES AND ORTHOSES;

ANIMALS; BODY TEMPERATURE; CIRCADIAN RHYTHM; ELECTROCARDIOGRAPHY; FEMALE; INTRAOCULAR PRESSURE; MACACA MULATTA; PROSTHESES AND IMPLANTS; TELEMETRY; TRANSDUCERS, PRESSURE;

EID: 84856397975     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7955     Document Type: Article

References (48)

1. Miglior S, Pfeiffer N, Torri V, Zeyen T, Cunha-Vaz J, Adamsons I. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology. 2007;114:3-9.
2. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121:48-56.
3. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-720; discussion 829-730.
4. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol. 2000;130:429-440.
5. The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol. 2002;134: 499-512.
6. Musch DC, Gillespie BW, Lichter PR, Niziol LM, Janz NK. Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors. Ophthalmology. 2009;116:200-207.
7. Caprioli J, Coleman AL. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Ophthalmology. 2008;115:1123-1129.
8. Rudnicka AR, Mt-Isa S, Owen CG, Cook DG, Ashby D. Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis. Invest Ophthalmol Vis Sci. 2006;47: 4254-4261.
9. Klein BE, Klein R, Linton KL. Intraocular pressure in an American community. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 1992;33:2224-2228.
10. Nomura H, Ando F, Niino N, Shimokata H, Miyake Y. The relationship between age and intraocular pressure in a Japanese population: the influence of central corneal thickness. Curr Eye Res. 2002;24:81-85.
11. Nomura H, Shimokata H, Ando F, Miyake Y, Kuzuya F. Age-related changes in intraocular pressure in a large Japanese population: a cross-sectional and longitudinal study. Ophthalmology. 1999;106: 2016-2022.
12. Rochtchina E, Mitchell P, Wang JJ. Relationship between age and intraocular pressure: the Blue Mountains Eye Study. Clin Exp Ophthalmol. 2002;30:173-175.
13. Weih LM, Mukesh BN, McCarty CA, Taylor HR. Association of demographic, familial, medical, and ocular factors with intraocular pressure. Arch Ophthalmol. 2001;119:875-880.
14. Leske MC, Connell AM, Wu SY, Hyman L, Schachat AP. Distribution of intraocular pressure. The Barbados Eye Study. Arch Ophthalmol. 1997;115:1051-1057.
15. Wu SY, Leske MC. Associations with intraocular pressure in the Barbados Eye Study. Arch Ophthalmol. 1997;115:1572-1576.
16. Chumbley LC, Brubaker RF. Low-tension glaucoma. Am J Ophthalmol. 1976;81:761-767.
17. Levene RZ. Low tension glaucoma: a critical review and new material. Surv Ophthalmol. 1980;24:621-664.
18. Geijssen H. Studies on Normal-Pressure Glaucoma. Amsterdam: Kugler Publications; 1991.
19. Burgoyne CF, Downs JC. Premise and prediction-how optic nerve head biomechanics underlies the susceptibility and clinical behavior of the aged optic nerve head. J Glaucoma. 2008;17:318-328.
20. Albon J, Purslow PP, Karwatowski WS, Easty DL. Age related compliance of the lamina cribrosa in human eyes. Br J Ophthalmol. 2000;84:318-323.
21. Girard MJ, Suh JK, Bottlang M, Burgoyne CF, Downs JC. Scleral biomechanics in the aging monkey eye. Invest Ophthalmol Vis Sci. 2009;50:5226-5237.
22. Knox Cartwright NE, Tyrer JR, Marshall J. Age-related differences in the elasticity of the human cornea. Invest Ophthalmol Vis Sci. June 2011;52:4324-4329.
23. Downs JC, Suh JK, Thomas KA, Bellezza AJ, Hart RT, Burgoyne CF. Viscoelastic material properties of the peripapillary sclera in normal and early-glaucoma monkey eyes. Invest Ophthalmol Vis Sci. 2005;46:540-546.
24. Girard MJ, Suh JK, Bottlang M, Burgoyne CF, Downs JC. Biomechanical changes in the sclera of monkey eyes exposed to chronic IOP elevations. Invest Ophthalmol Vis Sci. 2011;52:5656-5669.
25. Bengtsson B, Leske MC, Hyman L, Heijl A. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology. 2007;114:205-209.
26. Musch DC, Gillespie BW, Niziol LM, Lichter PR, Varma R; CIGTS Study Group. Intraocular pressure control and long-term visual field loss in the collaborative initial glaucoma treatment study. Ophthalmology. Published online May 19, 2011.
27. Medeiros FA, Weinreb RN, Zangwill LM, et al. Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma. Ophthalmology. 2008;115:934-940.
28. Bengtsson B, Heijl A. Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 2005;243:513-518.
29. Liu JH, Zhang X, Kripke DF, Weinreb RN. Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci. 2003;44:1586-1590.
30. Asrani S, Zeimer R, Wilensky J, Gieser D, Vitale S, Lindenmuth K. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma. 2000;9: 134-142.
31. Realini T, Weinreb RN, Wisniewski S. Short-term repeatability of diurnal intraocular pressure patterns in glaucomatous individuals. Ophthalmology. 2011;118:47-51.
32. Realini T, Weinreb RN, Wisniewski SR. Diurnal intraocular pressure patterns are not repeatable in the short term in healthy individuals. Ophthalmology. 2010;117:1700-1704.
33. Kotecha A, White E, Schlottmann PG, Garway-Heath DF. Intraocular pressure measurement precision with the Goldmann applanation, dynamic contour, and ocular response analyzer tonometers. Ophthalmology. 2010;117:730-737.
34. Pourjavan S, Boelle PY, Detry-Morel M, De Potter P. Physiological diurnal variability and characteristics of the ocular pulse amplitude (OPA) with the dynamic contour tonometer (DCT-Pascal). Int Ophthalmol. 2007;27:357-360.
35. Coleman DJ, Trokel S. Direct-recorded intraocular pressure variations in a human subject. Arch Ophthalmol. 1969;82:637-640.
36. Kaufmann C, Bachmann LM, Robert YC, Thiel MA. Ocular pulse amplitude in healthy subjects as measured by dynamic contour tonometry. Arch Ophthalmol. 2006;124:1104-1108.
37. Mansouri K, Shaarawy T. Continuous intraocular pressure monitoring with a wireless ocular telemetry sensor: initial clinical experience in patients with open angle glaucoma. Br J Ophthalmol. 2011;95:627-629.
38. McLaren JW, Brubaker RF, FitzSimon JS. Continuous measurement of intraocular pressure in rabbits by telemetry. Invest Ophthalmol Vis Sci. 1996;37:966-975.
39. McLaren JW, Bachman LA, Brubaker RF. Comparison of effects of topical ibopamine and epinephrine on the circadian rhythm of intraocular pressure of the rabbit eye as measured by telemetry. J Ocul Pharmacol Ther. 1999;15:107-116.
40. Akaishi T, Ishida N, Shimazaki A, Hara H, Kuwayama Y. Continuous monitoring of circadian variations in intraocular pressure by telemetry system throughout a 12-week treatment with timolol maleate in rabbits. J Ocul Pharmacol Ther. 2005;21:436-444.
41. Li R, Liu JH. Telemetric monitoring of 24 h intraocular pressure in conscious and freely moving C57BL/6J and CBA/CaJ mice. Mol Vis. 2008;14:745-749.
42. Markert M, Klumpp A, Trautmann T, Mayer K, Stubhan M, Guth B. The value added by measuring myocardial contractility 'in vivo' in safety pharmacological profiling of drug candidates. J Pharmacol Toxicol Methods. 2007;56:203-211.
43. Liu JH, Kripke DF, Hoffman RE, et al. Nocturnal elevation of intraocular pressure in young adults. Invest Ophthalmol Vis Sci. 1998;39:2707-2712.
44. Liu JH, Kripke DF, Twa MD, et al. Twenty-four-hour pattern of intraocular pressure in the aging population. Invest Ophthalmol Vis Sci. 1999;40:2912-2917.
45. Jorge J, Ramoa-Marques R, Lourenco A, et al. IOP variations in the sitting and supine positions. J Glaucoma.
46. Tsukahara S, Sasaki T. Postural change of IOP in normal persons and in patients with primary wide open-angle glaucoma and lowtension glaucoma. Br J Ophthalmol. 1984;68:389-392.
47. Liu JH, Bouligny RP, Kripke DF, Weinreb RN. Nocturnal elevation of intraocular pressure is detectable in the sitting position. Invest Ophthalmol Vis Sci. 2003;44:4439-4442.
48. Barger LK, Hoban-Higgins TM, Fuller CA. Gender differences in the circadian rhythms of rhesus monkeys. Physiol Behav. 2010;101: 595-600.